A Sharp Rally Divides Market Experts on Verbio's Prospects

Verbio shares surge on strong H1 results and regulatory support, yet analysts diverge on whether the rally has further room to run or if optimism is already priced in.

Shares of biofuel producer Verbio have staged a remarkable recovery, buoyed by a strong first-half performance that suggests the company has moved past its operational low point. This surge, however, has sparked a clear divergence of opinion among financial analysts, with some seeing further runway for growth and others cautioning that the stock's valuation may already reflect its improved prospects.

Fundamental Recovery Fuels Momentum

The driving force behind the recent share price strength is a demonstrable improvement in fundamentals. Attractive ethanol margins and a recovery in biofuel quota prices propelled a 45% increase in second-quarter EBITDA to €30.1 million. Furthermore, the net loss for the first half of the year narrowed to less than €1 million. This positive trajectory is supported by record production levels in Europe and improved utilization rates at the company's U.S. facilities. The market has rewarded this progress: closing at €28.58 yesterday, the stock trades just shy of its 52-week high. Over a twelve-month horizon, the equity has delivered a gain exceeding 200%.

Regulatory Tailwinds Provide Support

Beyond pure operational capacity, regulatory policy remains a decisive factor for the company's profitability. The removal of unreliable THG certificates from the market and a political decision to suspend the use of surplus quotas for 2025 and 2026 have alleviated market pressure, providing noticeable support for quota prices.

Analyst Consensus Fractures on Valuation

The changed landscape has prompted analysts to update their assessments, yet their conclusions on future potential vary significantly.

The research team at mwb research has adopted a decidedly bullish stance. They have sharply raised their price target from €18 to €28 and upgraded their recommendation to "Buy." Their optimism is rooted in anticipated revenue growth from the production ramp-up in the United States, coupled with rising biofuel prices expected as a result of Europe's RED-III directives.

In contrast, the analysis firm Jefferies maintains a more cautious "Hold" rating, despite increasing its price target from €21 to €25. These experts acknowledge the improved market environment but argue logically that this positive scenario is already largely factored into the current valuation of the shares.

The Crucial Test Ahead

The next significant milestone for Verbio is now set for the second half of 2026. This period will test management's ability to successfully execute the planned production ramp-up at its Bitterfeld site. Only a smooth implementation of this expansion, leading to further strengthened profitability, can justify the current bullish market expectations and sustainably support the present share price level.